​

Psychedelics for depression is a topic in the health domain with significant developments in policy, regulation, and public health impact.

Key developments include definium's lsd-based pill reduces depression symptoms in late-stage trial, trump signs executive order to expedite psychedelic drug review and reclassification, among other significant events and policy changes.

Source: Geo Health Space